re: biochemicals update so a month or two ago i bought a bunch of bioplastic stocks, but sold a lot once the stuff started to drop last month. but i did keep the weird australian stuff i had because it doesn't fluctuate with the market much. i had my first pop with one. climbed at eod last night in what was friday for australia. last time it went up 10% it went back down on Monday, so might happen again. It's been 7 australian cents for forever, but it seems to really want to spike one day. Leaf Resources Ltd 0.088 AUD+0.016 (22.22%) Mar 26, 4:10 PM GMT+11 · ASX: LER the other one i like is a bioplastics company that actually made a profit this last quarter. they aren't that speculative, they're a little boring--they have factories and make and sell stuff. it's not change-the-world bioplastic stuff, just trash bags, etc. but they are ramping up production at the factories and i plan on holding for a while. Secos Group Ltd 0.29 AUD0.00 (0.00%) Mar 26, 4:10 PM GMT+11 ASX: SES and then this one is that make-fabric-out-of-coconut-waste stock. god i actually bought it. totally speculative but they are waiting for word about a patent with grasim. this is the one i feel less excited about so it will probably be the one that triples. Nanollose Ltd ASX: NC6 A good buy in seems to be .11
I knew it. My brother-in-law just won't stop pressing it... he spent the whole Pandemic down in Mexico and now is in Florida with all the other Sycophants of the finance industry. Life is a party/ I can work from anywhere! No Masks here. Emergency Gaul bladder surgery. only 1 shot in the arm.... My wife is so upset.
You know the medical backlog is something we should consider. There is a play here like One Med... Cancer Dr's are working 24 hrs a day with all the people who put off a year coming in with a huge growth emerging on their body.. I have heard the backlog for medical care is really really huge....
-->Drive Shack initiated with a Buy at Craig-Hallum 08:32 DS Craig-Hallum analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrowGet Free Trial Show Related Items >> --Corning announces expansion of contract with DoD, HHS --Montrose Environmental initiated with an Equal Weight at Morgan Stanley 08:38 MEG Morgan Stanley analyst Matthew Sharpe initiated coverage of Montrose Environmental with an Equal Weight rating and $46 price target. He thinks Montrose's revenue growth should remain "strong" given what he sees as secular end-market tailwinds for the company's regulatory compliance, emergency response, permitting, engineering, and remediation solutions for commercial clients and he sees potential for margin expansion. However, Sharpe also thinks the stock is "priced for perfection" and that the current valuation leaves little room for expansion, he tells investors. --Porch.com initiated with a Buy at Craig-Hallum 08:36 PRCH Craig-Hallum analyst Jason Kreyer initiated coverage of Porch.com with a Buy rating and $27 price target. Kreyer believes the less than 5x sales multiple for Porch.com is a steal, relative to a comp group commanding more than double that valuation, the analyst tells investors in a research note. He sees additional long-term upside potential pushing shares to $40-$50, as the company executes on a robust U.S. real estate opportunity.
--Opko Health's BioReference Labs expands COVID-19 testing for schools 08:26 OPK BioReference… --Baxter a 'stock to own' into earnings and beyond, says JPMorgan 07:21 BAX JPMorgan analyst Robbie Marcus continues to view Baxter as a "stock to own" into the coming earnings season and beyond. The company's profile limits downside in the near-term, yet supports upside to a return to mid-single digit sales growth and double-digit earnings growth longer-term, Marcus tells investors in a research note. He would be buyer of the stock at these levels and keeps an Overweight rating on the name with a $94 price target. --Itron initiated with an Overweight at Piper Sandler 06:03 ITRI --ViewRay upgraded to Buy from Neutral at BTIG 05:30 VRAY BTIG analyst Marie Thibault upgraded ViewRay to Buy from Neutral with a $7 price target. The recovery in hospital capital equipment budgets, and positive management commentary during a chat this week points to MRIdian's "broadening appeal and improving visibility" on installation schedules, Thibault tells investors in a research note. As such, the analyst is "more bullish" on the mid-to-long-term outlook for ViewRay. Thibault's recent survey of 25 hospital purchasing decision-makers pointed to a "strong recovery" in overall capital equipment budgets over the next few months.
Olin upgraded to Outperform from Sector Perform at RBC Capital Benchmark starts 'small form battery play' Ultralife at Buy 07:09 ULBI As previously reported,… Back Later!
“Stocks that are not tech related are sneaking up. I came across MHLD at $2, bought some after earnings appeared less terrible. Bought more at $3 as they have been buying up preferred shares. CHS slowly add while buyers of the May $4s creep in. Next is DBI, another stock I like buying on pullbacks below $14. The option buying on the April/May $17.5-$20s has been good and lets me know it might be correct. CAL,LB are nice too. RAIL($4.80)”. I forgot to post this yesterday.